This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyazawa, J. Articles by Imai, K. Search for Related Content PubMed PubMed Citation Articles by Miyazawa, J. Articles by Imai, K.

Expression of Mesenchyme-Specific Gene HMGA2 in Squamous Cell Carcinomas of the Oral Cavity

¹ Departments of Oral and Maxillofacial Surgery and
² Biochemistry, Nippon Dental University, Tokyo, Japan;
³ Department of Oral Surgery, Kanazawa University, Kanazawa, Japan; and
⁴ Department of Biochemistry, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey

Carcinoma cells of epithelial origin are predisposed to acquire a fibroblastic feature during progression of neoplasm referred to as the epithelial-mesenchymal transition. HMGA2 is an architectural transcriptional factor that is expressed in the undifferentiated mesenchyme and initiates mesenchymal tumor formation. However, the biological consequence of the expression in the pathology of epithelial-type carcinomas is controversial. The present study was conducted to dissect the expression pattern in oral squamous cell carcinomas. HMGA2 was detected exclusively in carcinoma cell lines and tissues, but not in normal keratinocytes and gingival, by conventional reverse transcription-PCR. Quantitative real-time reverse transcription-PCR demonstrated 160-fold more HMGA2 expression in carcinoma tissues than in normal gingiva and 11-fold more HMGA2 expression in carcinoma cell lines than in normal keratinocytes. HMGA2 expression was observed by immunohistochemistry in 73.8% of 42 carcinomas and localized to the invasive front, where the cells exhibit the epithelial-mesenchymal transition. Fourteen patients who had been classified into a group without lymph node metastasis were positive for HMGA2 staining, and the disease recurred. Furthermore, carcinomas from all 23 patients who died of tumor recurrence stained for HMGA2, and HMGA2 staining was correlated to long-term survival of patients (P < 0.01). Multivariate risk factor analysis demonstrated that HMGA2 expression was an independent prognostic value for disease-specific overall survival (P < 0.01). These results suggest that HMGA2 contributes to the aggressiveness of carcinoma and that detection of HMGA2 expression is a useful predictive and prognostic tool in clinical management of oral carcinomas.

This article has been cited by other articles:

				T. Chiba, G. Maeda, S. Kawashiri, K. Kato, and K. Imai Epigenetic Loss of Mucosa-Associated Lymphoid Tissue 1 Expression in Patients with Oral Carcinomas Cancer Res., September 15, 2009; 69(18): 7216 - 7223. [Abstract] [Full Text] [PDF]

				H. Summer, O. Li, Q. Bao, L. Zhan, S. Peter, P. Sathiyanathan, D. Henderson, T. Klonisch, S. D. Goodman, and P. Droge HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy Nucleic Acids Res., July 1, 2009; 37(13): 4371 - 4384. [Abstract] [Full Text] [PDF]

				X. Liu, L. Wang, S. Zhang, J. Lin, S. Zhang, M. A. Feitelson, H. Gao, and M. Zhu Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses Carcinogenesis, June 1, 2008; 29(6): 1207 - 1214. [Abstract] [Full Text] [PDF]

				K. Motoyama, H. Inoue, Y. Nakamura, H. Uetake, K. Sugihara, and M. Mori Clinical Significance of High Mobility Group A2 in Human Gastric Cancer and Its Relationship to let-7 MicroRNA Family Clin. Cancer Res., April 15, 2008; 14(8): 2334 - 2340. [Abstract] [Full Text] [PDF]

				X. Cao, C. Clavijo, X. Li, H. H. Lin, Y. Chen, H.-M. Shih, and D. K. Ann SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome Mol. Cancer Ther., April 1, 2008; 7(4): 923 - 934. [Abstract] [Full Text] [PDF]

				G. Maeda, T. Chiba, S. Kawashiri, T. Satoh, and K. Imai Epigenetic Inactivation of I{kappa}B Kinase-{alpha} in Oral Carcinomas and Tumor Progression Clin. Cancer Res., September 1, 2007; 13(17): 5041 - 5047. [Abstract] [Full Text] [PDF]

				S. Shell, S.-M. Park, A. R. Radjabi, R. Schickel, E. O. Kistner, D. A. Jewell, C. Feig, E. Lengyel, and M. E. Peter Let-7 expression defines two differentiation stages of cancer PNAS, July 3, 2007; 104(27): 11400 - 11405. [Abstract] [Full Text] [PDF]

				G. Cattaruzzi, S. Altamura, M. A. Tessari, A. Rustighi, V. Giancotti, C. Pucillo, and G. Manfioletti The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and function Nucleic Acids Res., March 19, 2007; 35(6): 1751 - 1760. [Abstract] [Full Text] [PDF]

				S. Thuault, U. Valcourt, M. Petersen, G. Manfioletti, C.-H. Heldin, and A. Moustakas Transforming growth factor-{beta} employs HMGA2 to elicit epithelial-mesenchymal transition J. Cell Biol., July 17, 2006; 174(2): 175 - 183. [Abstract] [Full Text] [PDF]

				L. T. Smith, M. Lin, R. M. Brena, J. C. Lang, D. E. Schuller, G. A. Otterson, C. D. Morrison, D. J. Smiraglia, and C. Plass Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer PNAS, January 24, 2006; 103(4): 982 - 987. [Abstract] [Full Text] [PDF]

				L. M. Boo, H. H. Lin, V. Chung, B. Zhou, S. G. Louie, M. A. O'Reilly, Y. Yen, and D. K. Ann High Mobility Group A2 Potentiates Genotoxic Stress in Part through the Modulation of Basal and DNA Damage-Dependent Phosphatidylinositol 3-Kinase-Related Protein Kinase Activation Cancer Res., August 1, 2005; 65(15): 6622 - 6630. [Abstract] [Full Text] [PDF]